Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Single-Arm Trial to Test the Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use Disorder (CUD)

NCT06920238 is registered in ClinicalTrials.gov with Trustees of Dartmouth College as lead sponsor.

NCT NCT06920238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06920238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Single-Arm Trial to Test the Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use Disorder (CUD)
Lead sponsor
Trustees of Dartmouth College
Phase
Phase 1
Overall status
Completed
Start date
April 13, 2025
Completion date
April 28, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cannabis use disorder, depression - major depressive disorder, depression, anxiety